Cargando…
Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments
Glioblastoma is one of the most common and detrimental forms of solid brain tumor, with over 10,000 new cases reported every year in the United States. Despite aggressive multimodal treatment approaches, the overall survival period is reported to be less than 15 months after diagnosis. A widely used...
Autores principales: | Rajaratnam, Vilashini, Islam, Mohammad Mohiminul, Yang, Maixee, Slaby, Rachel, Ramirez, Hilda Martinez, Mirza, Shama Parveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226351/ https://www.ncbi.nlm.nih.gov/pubmed/32290213 http://dx.doi.org/10.3390/cancers12040937 |
Ejemplares similares
-
Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020) -
Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021) -
Streptococcus pyogenes: Pathogenesis and the Current Status of Vaccines
por: Wang, Jiachao, et al.
Publicado: (2023) -
Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015) -
Glioblastoma: Current
Status, Emerging Targets, and
Recent Advances
por: Thakur, Amandeep, et al.
Publicado: (2022)